Literature DB >> 15297524

Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent.

James M Barbeau1, Jennifer Goforth, Angela M Caliendo, Frederick S Nolte.   

Abstract

We determined the dynamic range, reproducibility, accuracy, genotype bias, and sensitivity of the TaqMan hepatitis C virus (HCV) analyte-specific reagent (ASR). Serum samples were processed using the MagNA Pure LC instrument and run on the COBAS TaqMan 48 analyzer. The performance characteristics of the ASR were also compared with those of the qualitative AMPLICOR and quantitative AMPLICOR MONITOR HCV tests. The ASR exhibited a >/=6-log(10) linear dynamic range and excellent reproducibility, with a mean coefficient of variation of 14%. HCV RNA concentration measured with the ASR agreed within an average of 0.42 log(10) (2.6-fold) of the labeled concentration with members of a standard reference panel. HCV genotypes 1 to 4 were amplified with similar efficiencies with the ASR. The ASR and AMPLICOR MONITOR viral load results were significantly correlated (r = 0.8898; P < 0.01), but the agreement was poor (mean difference, 0.45 +/- 0.35 log(10)) for 72 HCV RNA-positive clinical samples. However, 98.9% agreement between the ASR and qualitative AMPLICOR test results was found with 60 positive and 29 negative samples. Limiting-dilution experiments demonstrated that the limits of detection for ASR and AMPLICOR tests were 84 and 26 IU/ml, respectively. The performance characteristics of the TaqMan HCV ASR are appropriate for all clinical applications of HCV RNA testing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297524      PMCID: PMC497598          DOI: 10.1128/JCM.42.8.3739-3746.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.

Authors:  T J Legler; J Riggert; G Simson; C Wolf; A Humpe; U Munzel; A Uy; M Köhler; K H Heermann
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

2.  Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.

Authors:  C Sarrazin; G Teuber; R Kokka; H Rabenau; S Zeuzem
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

3.  Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group.

Authors:  J Saldanha; N Lelie; A Heath
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

4.  Medical devices; classification/reclassification; restricted devices; analyte specific reagents--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1997-11-21

5.  Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant.

Authors:  A Doglio; C Laffont; F X Caroli-Bosc; P Rochet; J Lefebvre
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay.

Authors:  S Kawai; O Yokosuka; T Kanda; F Imazeki; Y Maru; H Saisho
Journal:  J Med Virol       Date:  1999-06       Impact factor: 2.327

7.  Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.

Authors:  S C Lee; A Antony; N Lee; J Leibow; J Q Yang; S Soviero; K Gutekunst; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

8.  Real-time detection system for quantification of hepatitis C virus genome.

Authors:  T Takeuchi; A Katsume; T Tanaka; A Abe; K Inoue; K Tsukiyama-Kohara; R Kawaguchi; S Tanaka; M Kohara
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

9.  Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay.

Authors:  B Mercier; L Burlot; C Férec
Journal:  J Virol Methods       Date:  1999-01       Impact factor: 2.014

10.  Standardized hepatitis C virus RNA panels for nucleic acid testing assays.

Authors:  P A Jorgensen; P D Neuwald
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

View more
  13 in total

1.  Primer sequence modification enhances hepatitis C virus genotype coverage.

Authors:  Yi-Wei Tang; Susan E Sefers; Haijing Li
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Multicenter trials need to use the same assay for hepatitis C virus viral load determination.

Authors:  Syria Laperche; Françoise Bouchardeau; Vincent Thibault; Bruno Pozzetto; Sophie Vallet; Arielle R Rosenberg; Anne-Marie Roque-Afonso; Michèle Gassin; Françoise Stoll-Keller; Pascale Trimoulet; Elyanne Gault; Bruno Chanzy; Bernard Mercier; Michel Branger; Jean-Michel Pawlotsky; Cécile Henquell; Françoise Lunel; Catherine Gaudy-Graffin; Sophie Alain; Marie-Laure Chaix; Gilles Duverlie; Jacques Izopet; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

3.  Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits.

Authors:  Syria Laperche; Françoise Bouchardeau; Elisabeth André-Garnier; Vincent Thibault; Anne-Marie Roque-Afonso; Pascale Trimoulet; Ronald Colimon; Gilles Duverlie; Hélène Leguillou-Guillemette; Françoise Lunel; Magali Bouvier-Alias; Jean-Michel Pawlotsky; Cécile Henquell; Evelyne Schvoerer; Françoise Stoll-Keller; Marie-Laure Chaix; Michel Branger; Catherine Gaudy-Graffin; Arielle R Rosenberg; Bruno Pozzetto; Sophie Vallet; Yazid Baazia; Jacques Izopet; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

4.  Quantification of hepatitis B virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC instrument.

Authors:  Jeffrey J Germer; Mohammed O Qutub; Jayawant N Mandrekar; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Broad differences between the COBAS ampliprep total nucleic acid isolation-COBAS TaqMan 48 hepatitis C virus (HCV) and COBAS HCV monitor v2.0 assays for quantification of serum HCV RNA of non-1 genotypes.

Authors:  Philippe Colson; Anne Motte; Catherine Tamalet
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Multilaboratory comparison of hepatitis C virus viral load assays.

Authors:  A M Caliendo; A Valsamakis; Y Zhou; B Yen-Lieberman; J Andersen; S Young; A Ferreira-Gonzalez; G J Tsongalis; R Pyles; J W Bremer; N S Lurain
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.

Authors:  Michael S Forman; Alexandra Valsamakis
Journal:  J Mol Diagn       Date:  2008-02-14       Impact factor: 5.568

8.  Detection and quantification of hepatitis C virus (HCV) by MultiCode-RTx real-time PCR targeting the HCV 3' untranslated region.

Authors:  Elizabeth K Mulligan; J J Germer; Max Q Arens; Krista L D'Amore; Adrian Di Bisceglie; Nathan A Ledeboer; Michael J Moser; Andrew C Newman; Andy K O'Guin; Paul D Olivo; Diane S Podzorski; Kimberly A Vaughan; Joseph D Yao; Slava A Elagin; Scott C Johnson
Journal:  J Clin Microbiol       Date:  2009-06-17       Impact factor: 5.948

9.  Anomalous quantitation standard growth curves in a laboratory-developed hepatitis C virus (HCV) RNA quantification assay using the TaqMan HCV analyte-specific reagent.

Authors:  Jeffrey J Germer; Jemee D Kathrotiya; Carrie F Bouse; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Comparison of performance characteristics of three real-time reverse transcription-PCR test systems for detection and quantification of hepatitis C virus.

Authors:  M Fernanda Sábato; Mitchell L Shiffman; Michael R Langley; David S Wilkinson; Andrea Ferreira-Gonzalez
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.